Acrivon Therapeutics Inc
NASDAQ:ACRV
Cash Flow Statement
Cash Flow Statement
Acrivon Therapeutics Inc
| Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
(29)
|
(31)
|
(44)
|
(45)
|
(50)
|
(60)
|
(64)
|
(69)
|
(77)
|
(81)
|
(84)
|
(86)
|
(82)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
2
|
5
|
7
|
10
|
12
|
12
|
13
|
14
|
14
|
15
|
15
|
15
|
|
| Other Non-Cash Items |
2
|
2
|
4
|
5
|
8
|
9
|
10
|
11
|
11
|
11
|
12
|
13
|
15
|
|
| Change in Working Capital |
1
|
(2)
|
(2)
|
3
|
2
|
8
|
5
|
4
|
4
|
2
|
2
|
0
|
(0)
|
|
| Cash from Operating Activities |
(27)
N/A
|
(30)
-13%
|
(41)
-38%
|
(36)
+12%
|
(40)
-9%
|
(43)
-8%
|
(48)
-13%
|
(53)
-10%
|
(61)
-14%
|
(66)
-8%
|
(68)
-4%
|
(71)
-4%
|
(66)
+7%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
| Other Items |
(45)
|
(140)
|
(130)
|
(111)
|
(65)
|
52
|
49
|
(58)
|
(43)
|
(49)
|
(36)
|
71
|
61
|
|
| Cash from Investing Activities |
(47)
N/A
|
(142)
-203%
|
(132)
+7%
|
(112)
+16%
|
(65)
+42%
|
51
N/A
|
47
-7%
|
(60)
N/A
|
(46)
+24%
|
(52)
-13%
|
(38)
+26%
|
69
N/A
|
59
-15%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
100
|
2
|
0
|
2
|
2
|
(0)
|
(0)
|
123
|
123
|
124
|
124
|
(0)
|
0
|
|
| Other |
(0)
|
100
|
100
|
100
|
100
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
|
| Cash from Financing Activities |
100
N/A
|
102
+2%
|
102
N/A
|
102
+0%
|
102
+0%
|
(2)
N/A
|
(2)
-11%
|
121
N/A
|
120
-1%
|
121
+1%
|
121
0%
|
(3)
N/A
|
(1)
+54%
|
|
| Change in Cash | ||||||||||||||
| Net Change in Cash |
26
N/A
|
(70)
N/A
|
(72)
-3%
|
(46)
+37%
|
(2)
+95%
|
7
N/A
|
(3)
N/A
|
8
N/A
|
13
+68%
|
4
-73%
|
14
+299%
|
(4)
N/A
|
(8)
-85%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(29)
N/A
|
(32)
-12%
|
(44)
-35%
|
(37)
+15%
|
(40)
-8%
|
(44)
-10%
|
(50)
-15%
|
(55)
-10%
|
(64)
-15%
|
(68)
-7%
|
(70)
-2%
|
(73)
-4%
|
(68)
+7%
|
|